SNDX Earnings

Quarterly EPS
$-0.98
Q3 2024
$-1.09
Q4 2024
$-0.98
Q1 2025
$-0.83
Q2 2025
$-0.70
Q3 2025
$-0.78
Q4 2025
$-0.48
Q1 2026
$-0.55
Q2 2026
Latest Revenue72.8M
Latest Net Income-49363000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.5572.8M-49363000+91.8%+33.7%
Q1 2026-$0.4864.9M-42673000+223.6%+51.0%
Q4 2025-$0.7868.7M-68014000+794.9%+28.4%
Q3 2025-$0.7045.9M-60715000+267.0%+28.6%
Q2 2025-$0.8338.0M-71847000+984.5%-3.7%
Q1 2025-$0.9820.0M-84846000-15.3%
Q4 2024-$1.097.7M-94169000-9.0%
Q3 2024-$0.9812.5M-84126000-34.2%
Q2 2024-$0.803.5M-68063000
Q1 2024-$0.850-72400000
Q4 2023-$1.000-72473000
Q3 2023-$0.730-51146000
Syndax Pharmaceuticals (SNDX) — Earnings